Regulatory issues for phage-based clinic
β
Roger Withington
π
Article
π
2001
π
Wiley (John Wiley & Sons)
π
English
β 62 KB
## Abstract Phageβbased therapeutic products are members of a growing and diverse group of products categorised as βbiologicsβ, βbiologicalsβ or βbiotechnological productsβ. They are regulated in much the same way as conventional drugs although in America they have their own division at FDA, the Ce